In this study, the use of Src/Abl inhibitor in HPV-positive cervical cancer cell lines (SiHa and HeLa) was found to restore β-catenin accompanied by the downregulation of FSCN1 expression pattern, thus inhibiting cell invasion ability of these cancer cell lines [122]. Here, FSCN1 is linked to cervical carcinoma.